Author: Haverkate F.
Publisher: Elsevier
ISSN: 0306-3623
Source: General Pharmacology, Vol.39, Iss.3, 2002-08, pp. : 109-112
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Smoking, Haemostatic Factors, and Cardiovascular Risk
Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. :
Cardiovascular risk factors in progressive renal disease
By Harris KPG
Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. :
Rimonabant reduces risk factors for cardiovascular disease
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :